Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
TargetMol | Compound Library

Bioactive Compound Library

Catalog No. L4000

It contains more than 17760 small molecule compounds, with known biological activities causing biological reaction in cells, tissue even whole body, including Clinical compound library (L3400), Preclinical compound library (L3410), and Approved drug library (L1000). All compounds have clear targets and detailed information description, which is the key point to drug research and development like drug repurposing, small molecule inducing stem cell differentiation, and target identification in mechanism interrogation.

Many scientists have identified small molecules that can regulate cell fate and function, and stem cell differentiation by screening annotated bioactive compound library with confirmed activity and known targets. Recent advances in iPSC technology have made reprogramming of somatic cells towards pluripotency possible and simpler. Using both phenotypic screening and hypothesis-driven approaches, a growing number of compounds have been identified that can functionally replace reprogramming transcription factors, enhance efficiency of iPSC generation and accelerate the reprogramming process by single use or a combination of several molecules with success in cardiomyocyte differentiation and proliferation, neural progenitor cells, etc.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

Resource Download
Library compound info
Excel
SDF
Contact us for more batch information

Catalog No. L4000

Bioactive Compound Library

sizeIn stock

  • 1 mg
  • 30 μL x 10 mM (in DMSO)
  • 50 μL x 10 mM (in DMSO)
  • 100 μL x 10 mM (in DMSO)
  • 250 μL x 10 mM (in DMSO)
Inquiry & Custom

Top Publication Citing
Use of TargetMol Products

Cite scientific literature on TargetMol products

View More

Product Description Product Description

  • A collection of 17760 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;
  • All compounds have clear targets;
  • An effective tool for discovering new with old drugs, cell induction, and new drug target screening;
  • Covers various disease research areas, such as Cancer, Metabolism, Immunology and Cardiovascular system, etc.
  • Detailed compound information with structure, target, activity, IC50 value, and brief introduction;
  • Structurally diverse, medicinally active, and cell permeable;
  • NMR and HPLC validated to ensure high purity and quality;

Advantages Introduction Advantages Introduction

High-Standard Entry Criteria

TargetMol's Bioactive Compounds Library is established upon rigorous entry standards to ensure that every compound included is structurally well-defined and of exceptional purity, verified through multiple analytical techniques such as NMR, HPLC, and LC-MS. Our multi-layered screening mechanism effectively eliminates compounds with ambiguous structures, such as mixtures and polymers. Moreover, we specifically exclude substances like sunscreens, contrast agents, dyes, fragrances, plastic additives, and intermediates—compounds typically lacking biological activity due to their specificity and stability, which generally prevent interactions with biological systems. This meticulous curation reduces time and resource waste caused by ineffective screenings.

Significant Structural Diversity

TargetMol’s Bioactive Compounds Library features extensive scaffold diversity and structural complexity, offering a substantial advantage in drug discovery. Based on the Bemis-Murcko scaffold classification, our library is categorized into 10,102 unique classes, each representing a distinct molecular scaffold, thereby extensively covering a broad chemical space. The compounds range from simple to highly complex structures, providing a diverse foundation for identifying lead compounds with strong affinity and specificity toward target proteins. This structural richness significantly advances pharmaceutical innovation. Whether targeting traditional drug targets or emerging, more challenging ones, our Bioactive Compounds Library offers a wealth of candidate molecules to accelerate the drug development process.

 Bioactive Compound Library
Library Diversity Analysis

Superior Drug-Like Properties

67% of the compounds in TargetMol's Bioactive Compounds Library comply with Lipinski’s "Rule of Five" (Ro5), indicating excellent bioavailability and permeability.

 Bioactive Compound Library  Bioactive Compound Library
 Bioactive Compound Library  Bioactive Compound Library
 Bioactive Compound Library  Bioactive Compound Library

Multidimensional Pharmacokinetic Analysis

A multidimensional evaluation is conducted on TargetMol’s Bioactive Compounds Library, which systematically analyzes three key pharmacological parameters: blood-brain barrier permeability, cardiotoxicity (HERG K+ channel inhibition), and oral absorption performance.

 Bioactive Compound Library  Bioactive Compound Library  Bioactive Compound Library

14% of the compounds can cross the blood-brain barrier, while 86% cannot.
49% of the compounds exhibit cardiotoxicity, while 51% do not.
54% of the compounds are highly orally absorbable.

Diverse Compound Collection

TargetMol's Bioactive Compound Library covers a wide variety of compounds with diverse biological activities. This includes marketed drugs, drug candidates in clinical trials, and compounds with reported biological activities in the literature. The library encompasses not only mainstream signaling pathways and targets but also numerous emerging therapeutic targets. It spans various therapeutic areas, including cancer, cardiovascular diseases, and neurological disorders.

 Bioactive Compound Library  Bioactive Compound Library
 Bioactive Compound Library  Bioactive Compound Library

Regular Updates to Compound Libraries

We ensure our compound libraries remain at the forefront of scientific research by regularly updating our database with compounds mentioned in cutting-edge literature and newly custom-synthesized compounds.

Flexible Packaging Options

We offer a variety of standard packaging sizes (e.g., 30 μL, 50 μL, 100 μL, 250 μL, 1 mg), and we can customize packaging solutions to meet specific needs.

Customized Services

To support specific needs, we offer tailored screening services, including the design and synthesis of customized compound libraries and the execution of personalized screening projects. Our highly flexible service model is designed to efficiently meet unique needs of scientists and accelerate breakthrough discoveries.

Packaging And Storage | TargetMol Packaging And Storage

  • Powder or pre-dissolved DMSO solutions in 96/384 well plate with optional 2D barcode
  • Shipped with blue ice

Sci Citations

Library Customization | TargetMol Library Customization

Compound Library | TargetMol
Targetmol Compound Libraries
can be highly customized!
Inquiry & Custom

Library Customization | TargetMol Library Composition

Apoptosis
Antibacterial
Endogenous Metabolite
Autophagy
Antibiotic
5-HT Receptor
AChR
Antifungal
Parasite
Adrenergic Receptor
DNA/RNA Synthesis
NF-κB
COX
Dopamine Receptor
Calcium Channel
CDK
HIV Protease
Potassium Channel
Antioxidant
PI3K
EGFR
Histamine Receptor
Dehydrogenase
Cytochromes P450
Epigenetic Reader Domain
Sodium Channel
PDE
GABA Receptor
Reactive Oxygen Species
VEGFR
GluR
Histone Methyltransferase
Influenza Virus
TRP/TRPV Channel
PPAR
Microtubule Associated
HDAC
TNF
Wnt/beta-catenin
GPCR
Phosphatase
Cholinesterase (ChE)
JAK
mTOR
Akt
Topoisomerase
p38 MAPK
Prostaglandin Receptor
SARS-CoV
Estrogen/progestogen Receptor
Antiviral
ERK
Src
Ferroptosis
RAAS
PKC
FLT
Adenosine Receptor
PARP
NMDAR
IL Receptor
HCV Protease
STAT
Opioid Receptor
Nucleoside Antimetabolite/Analog
Estrogen Receptor/ERR
iGluR
PDGFR
AMPK
MMP
Caspase
FGFR
Virus Protease
Bcl-2 Family
NO Synthase
GSK-3
Glucocorticoid Receptor
Raf
Androgen Receptor
MAO
Lipoxygenase
TLR
ROS
Beta Amyloid
c-Kit
HSP
Cannabinoid Receptor
ATPase
HBV
Phospholipase
c-Met/HGFR
Bcr-Abl
ALK
Proteasome
TGF-beta/Smad
Mitochondrial Metabolism
HSV
Drug Metabolite
Sirtuin
Tyrosinase
Nrf2
MAPK
Anti-infection
HIF/HIF Prolyl-Hydroxylase
Histone Demethylase
NOS
DUB
JNK
Integrin
Aurora Kinase
Ras
PKA
Antifection
Mitophagy
Tyrosine Kinases
p53
E1/E2/E3 Enzyme
Transferase
ROCK
CCR
Carbonic Anhydrase
HIF
P-gp
Casein Kinase
MEK
IκB/IKK
Reverse Transcriptase
Gamma-secretase
Monoamine Oxidase
Immunology/Inflammation related
S1P Receptor
Norepinephrine
Interleukin
Neurokinin receptor
Serotonin Transporter
Retinoid Receptor
PROTACs
Reductase
Cysteine Protease
CXCR
Serine/threonin kinase
RIP kinase
P2X Receptor
Glucosidase
IGF-1R
c-RET
Serine Protease
FAK
LPL Receptor
CaMK
DNA-PK
Hedgehog/Smoothened
NOD
Histone Acetyltransferase
TAM Receptor
Glucokinase
S6 Kinase
Sigma receptor
FAAH
Trk receptor
ATM/ATR
Fatty Acid Synthase
transporter
HER
Chloride channel
PERK
c-Fms
Proton pump
NADPH
Progesterone Receptor
DPP-4
HMG-CoA Reductase
CFTR
Amino Acids and Derivatives
Acyltransferase
ribosome
PLK
Syk
Pim
Neuropeptide Y Receptor
Endothelin Receptor
DNA
Protease-activated Receptor
Mdm2
Rho
Chk
DNA Methyltransferase
Thrombin
LTR
Glucagon Receptor
Cholecystokinin Receptor
Aryl Hydrocarbon Receptor
cAMP
Kinesin
DHFR
Smo
STING
AhR
Thyroid hormone receptor(THR)
ROR
DNA Alkylator/Crosslinker
P2Y Receptor
Factor Xa
Leukotriene Receptor
FXR
LPA Receptor
Melanocortin Receptor
IRAK
PD-1/PD-L1
BACE
Lipase
MRP
SGLT
PDK
Complement System
BTK
DYRK
Glutathione Peroxidase
Guanylate cyclase
Xanthine Oxidase
Epoxide Hydrolase
Indoleamine 2,3-Dioxygenase (IDO)
LRRK2
Hydroxylase
ADC Cytotoxin
YAP
GNRH Receptor
Bradykinin Receptor
Vasopressin Receptor
OX Receptor
Platelet aggregation
c-Myc
DNA Alkylation
Kras
Liver X Receptor
PAK
RSV
Aromatase
GTPase
IAP
Ephrin Receptor
ROS Kinase
Myosin
IRE1
ABC Transporter
PGE Synthase
Ligand for E3 Ligase
NOD-like Receptor (NLR)
Antifolate
Neurotensin Receptor
CSF-1R
Telomerase
PI4K
GHSR
LDL
Lipid
Beta-Secretase
Acetyl-CoA Carboxylase
NADPH-oxidase
MicroRNA
Monocarboxylate transporter
Monoamine Transporter
Molecular Glues
Somatostatin
Aminopeptidase
GPCR19
PAI-1
Arrestin
CaSR
Glutaminase
DNA gyrase
Stearoyl-CoA Desaturase (SCD)
Discoidin Domain Receptor (DDR)
Ligands for Target Protein for PROTAC
IFNAR
CETP
Melatonin Receptor
NAMPT
IDO
GRK
Phosphorylase
Isocitrate Dehydrogenase (IDH)
MNK
Free radical scavengers
GPX
PKM
Dynamin
UGT
PAFR
Bombesin Receptor
BCRP
OAT
Imidazoline Receptor
Apelin receptor
Adenylyl Cyclase
Arginase
LIM Kinase
MT Receptor
Angiotensin-converting Enzyme (ACE)
PAD
ATP Citrate Lyase
Porcupine
GST
SGK
Gap Junction Protein
MLK
Na+/Ca2+ Exchanger
Tie-2
OCT
SIK
GlyT
PTEN
Wee1
ASK
Neprilysin
Carboxypeptidase
Protease
APC/C
Melanin-concentrating Hormone Receptor (MCHR)
MyD88
AAK1
PYK2
Annexin A
MAGL
cGAS
TSH Receptor
CRFR
Methionine Adenosyltransferase (MAT)
Oxytocin Receptor
CGRP Receptor
p97
RAR/RXR
MALT
CRM1
Amylase
FLAP
HCN Channel
Survivin
Decarboxylase
MELK
CRISPR/Cas9
Adenosine Deaminase
DAPK
NEDD8
DprE1
Cell wall
TOPK
Cell Cycle Arrest
MTH1
ACK1
MRGPR
CD73
Pyroptosis
Hippo pathway
Aquaporin
BMI-1
Advanced Glycation End Products
NPC1L1
CD38
gp120/CD4
Galectin
VDAC
Hck
Vitamin
RANKL/RANK
Adiponectin Receptor
Hexokinase
Thrombopoietin Receptor
OXPHOS
AIM2
FOXO3
Transaminase
Necroptosis
Kisspeptin
FABP
Haspin Kinase
Na-K-Cl cotransporter
KSP
PSMA
Glutathione reductase
CPT
GluCls
HuR
KLF
Liposome
Taste receptor
GSNOR
NUDIX hydrolase
Piezo Channel
EBI2/GPR183
Glutaminyl Cyclase
VDA
FOXO1
Prolyl Endopeptidase (PREP)
Fas/FasL
PACAP
Integrase
PROTAC Linker
Transketolase
Huntingtin
hCE
RXFP receptor
ATTECs
Lysosomal Autophagy
Glyoxalase
OLIG2
ADC Linker
PGK1
stilbene oxidase
Hydrogenase
CYP19A1
Procollagen C Proteinase
Aconitase
Neuropeptide W
LHRH
N-Acetylglucosaminyltransferase
Photosensitizer
Stemness kinase
Motilin Receptor
Endonuclease
Anion Exchanger
Thioredoxin
glycosidase
Mucin
FKBP
Cuproptosis
REV-ERB
MDM-2/p53
Fer/FerT kinase
NMU2R
Sodium-dependent phosphate transporter
PGC-1α
IGF-2R